CRISPR

YTD

ALL

Trade CRISPR 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About CRSP

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA.

CEO

Samarth Kulkarni

CEOSamarth Kulkarni

Employees

—

Employees—

Headquarters

Zug, Zug

HeadquartersZug, Zug

Founded

2013

Founded2013

Employees

—

Employees—

CRSP Key Statistics

Market cap

4.77B

Market cap4.77B

Price-Earnings ratio

-10.37

Price-Earnings ratio-10.37

Dividend yield

—

Dividend yield—

Average volume

1.44M

Average volume1.44M

High today

$49.89

High today$49.89

Low today

$48.02

Low today$48.02

Open price

$49.31

Open price$49.31

Volume

1.93M

Volume1.93M

52 Week high

$68.71

52 Week high$68.71

52 Week low

$44.12

52 Week low$44.12

Stock Snapshot

CRISPR(CRSP) stock is priced at $49.60, giving the company a market capitalization of 4.77B. It carries a P/E multiple of -10.37.

During the trading session on 2026-10-23, CRISPR(CRSP) shares reached a daily high of $49.89 and a low of $48.02. At a current price of $49.60, the stock is +3.3% higher than the low and still -0.6% under the high.

Trading volume for CRISPR(CRSP) stock has reached 1.93M, versus its average volume of 1.44M.

Over the past 52 weeks, CRISPR(CRSP) stock has traded between a high of $68.71 and a low of $44.12.

CRSP News

Zacks 14h

Investors Heavily Search CRISPR Therapeutics AG: Here is What You Need to Know

CRISPR Therapeutics AG (CRSP Quick QuoteCRSP - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to...

Zacks 1d

CRISPR Therapeutics AG Stock Moves -1.21%: What You Should Know

CRISPR Therapeutics AG (CRSP Quick QuoteCRSP - Free Report) closed the most recent trading day at $49.89, moving -1.21% from the previous trading session....

TipRanks 1d

Crispr Therapeutics Expands Into Autoimmune Neurology With New CTX112 Trial

Crispr Therapeutics (CRSP) announced an update on their ongoing clinical study. Crispr Therapeutics (CRSP) has launched a new early-stage study called “A Phase...

Analyst ratings

57%

of 23 ratings

Buy

56.5%

Hold

43.5%

Sell

More CRSP News

Simply Wall St 2d

CRISPR Therapeutics Stock Looks Pricey After A 46% Five Year Slump - Simply Wall Street

...

TipRanks 4d

CRISPR Therapeutics Appoints Andrew Silver as New CFO

Crispr Therapeutics AG ( (CRSP) ) just unveiled an announcement. On October 19, 2026, CRISPR Therapeutics AG promoted Andrew J. Silver, previously Senior Vice...

People also own

Based on the portfolios of people who own CRSP. This list is generated using Robinhood data, and it’s not a recommendation.

Intellia Therapeutics

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.